BIOPHARMACEUTICAL CLASSIFICATION SYSTEM AND BIOWAVER: AN OVERVIEW
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2011, Vol 2, Issue 5
Abstract
The biopharmaceutical classification system (BCS) has been developed to provide a scientific approach for classifying drug compounds based on solubility as related to dose and intestinal permeability in combination with the dissolution properties of the oral immediate release dosage form. BCS is to provide a regulatory tool for replacing certain bioequivalence (BE) studies by accurate in vitro dissolution tests. This review gives three dimensionless numbers which are used in BCS are absorption number, dissolution number, dose number. Biowaver is an important tool for formulation development. Bioavailability (BA) and BE play a central role in pharmaceutical product development, and BE studies are presently being conducted for New Drug Applications (NDAs) of new compounds, in supplementary NDAs for new medical indications and product line extensions, in Abbreviated New Drug Applications (ANDAs) of generic products, and in applications for scale-up and post-approval changes. The principles of the BCS classification system can be applied to NDA and ANDA approvals as well as to scale-up and post approval changes in drug manufacturing. BCS classification can therefore save pharmaceutical companies a significant amount in development time and reduce costs. The aim of the present review is to present the status of BCS and discuss its future application in pharmaceutical product development.
Authors and Affiliations
Prashant Puranik , Ashok Kasar , Deepak Gadade , Prabha Mali
Keywords
Related Articles
- EP ID EP134985
- DOI -
- Views 114
- Downloads 0
SUSTAINED RELEASE DEVICE CONTAINING ORNIDAZOLE FOR PERIODONTITIS
The purpose of this study was to develop a sustained release device containing ornidazole for insertion within periodontal pockets. Cast films of ethyl cellulose with dibutyl phthalate as plasticizer, containing ornidazo...
CLINICAL EVALUATION OF ‘SUSPEND’ TRIAL WITH HERBAL PREPARATION AND TAMSULOSIN: A MEDICAL EXPULSIVE THERAPY FOR UROLITHIASIS
Lithiasis occurs in various forms and at various sites in the body and the most common site is urinary tract. Urinary stones are one of the major problems and an important cause of morbidity and end stage renal failure i...
A RARE CASE OF RECURRENT FIXED DRUG ERUPTION AND LIP EDEMA DUE TO NORFLOXACIN AND TINIDAZOLE FIXED DOSE COMBINATION
Fixed drug eruption (FDE) is one of the common manifestations of cutaneous drug induced reactions. These are mainly caused by antibiotic and analgesic preparations. Many of the fixed dose combinations available in the ma...
PROTECTIVE EFFECT OF SPIRULINA ON ETHYLENE GLYCOL INDUCED UROLITHIASIS IN RATS
The aim of our present study is to assess the effects of spirulina as a preventive agent in experimentally induced urolithiasis model in rats. Rats were induced to produce kidney stone by providing drinking water contain...
SKIN KINETICS AND DERMAL CLEARANCE
Availability of several therapeutic and cosmetic formulations for topical application has made the research on skin kinetics as a topic of current interest. Topical formulations are typically meant for local effect altho...